In addition, the regucalcin and anti-regucalcin antibody levels in the serum of 143 patients with HCC were compared to those in serum samples from 137 patients with chronic hepatitis, 51 individuals with liver cirrhosis, and 165 healthy control participants [67]. Here, RGN is linked to hepatocellular carcinoma.